Category: Disease Discoveries
-
Biomarker Predicts Cognitive Decline in Alzheimer’s Disease
A biomarker in the brain predicts future cognitive decline in patients with the language form of Alzheimer’s disease (AD), reports a new Northwestern Medicine study.
-
Investigating COVID-19: Vaccine Effectiveness, Mechanisms of Infection and Child Hospitalization
Northwestern Medicine scientists continue to investigate all aspects of the COVID-19 pandemic: from molecular mechanisms of infection, to child hospitalization and single-dose vaccine response.
-
Uncovering Epigenetic Mechanisms Regulating Glioma Growth
Northwestern Medicine investigators have discovered the epigenetic mechanisms involved in the regulation of two oncogenes in glioma cells, which may improve personalized approaches to treat these cancers.
-
Fluorescent Label Passes Through Blood-Brain Barrier
Fluorescent indocarbocyanine lipid labels show improved distribution within glioblastoma brain tumors, according to a Northwestern Medicine study.
-
New Version of COVID-19 Vaccine Controls Breakthrough Infections Better
A new combination COVID-19 vaccine improved protection against breakthrough infections in mice, according to a recent Northwestern Medicine study.
-
Hypoxic Inflammation Blunts Repair After Heart Attack
Inefficient cardiac repair after heart attacks is partially driven by a maladapted response to a low oxygen environment by immune cells, according to a study published in the Journal of Experimental Medicine.
-
Study Identifies Genetic Variants Associated with COVID-19 Severity
In collaboration with Northwestern Medicine investigators, an international multi-center study has identified genetic factors associated with SARS-CoV-2 infection and COVID-19 severity.
-
Gene Implicated in Poor Skin Cancer Therapy Outcomes
Losing a check on T-cell activation in cutaneous T-cell lymphoma cells is associated with poor outcomes, according to a study published in Blood.
-
Nanoparticles Could Boost Immunotherapy
Enhancing the anti-cancer function of natural killer cells with nanoparticles could unlock their therapeutic potential, according to a Northwestern Medicine study.
-
CARDIA Study Enters 35th Year
Thirty-five years since it was started, the Coronary Artery Risk Development in Young Adults study, or CARDIA, has become a premier source for the determinants, mechanism and outcomes of cardiovascular disease and manifestations of aging.
